TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 199 filers reported holding TG THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $291,764 | -77.1% | 34,900 | -31.8% | 0.00% | -75.0% |
| Q2 2023 | $1,271,808 | +5.3% | 51,200 | -36.2% | 0.01% | 0.0% |
| Q1 2023 | $1,207,712 | +74.8% | 80,300 | +37.5% | 0.01% | +71.4% |
| Q4 2022 | $690,872 | +119.4% | 58,400 | +9.8% | 0.01% | +75.0% |
| Q3 2022 | $314,944 | +121.8% | 53,200 | +257.0% | 0.00% | +300.0% |
| Q1 2022 | $142,000 | -57.7% | 14,900 | -15.8% | 0.00% | -50.0% |
| Q4 2021 | $336,000 | -25.0% | 17,700 | +90.3% | 0.00% | -50.0% |
| Q1 2021 | $448,000 | -32.7% | 9,300 | -27.3% | 0.00% | -42.9% |
| Q4 2020 | $666,000 | -13.3% | 12,800 | -55.4% | 0.01% | -22.2% |
| Q3 2020 | $768,000 | -50.2% | 28,700 | -63.8% | 0.01% | -50.0% |
| Q2 2020 | $1,543,000 | +35.0% | 79,200 | -31.8% | 0.02% | +12.5% |
| Q1 2020 | $1,143,000 | +14.0% | 116,200 | +28.5% | 0.02% | +45.5% |
| Q4 2019 | $1,003,000 | +377.6% | 90,400 | +141.7% | 0.01% | +450.0% |
| Q3 2019 | $210,000 | – | 37,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |